A Pilot Phase II Study of Capecitabine plus Cisplatin in the Treatment of Recurrent Carcinoma of the Uterine Cervix

Publisher： Karger

E-ISSN： 1423-0232|72|1-2|33-38

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.1-2, 2007-11, pp. : 33-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vinorelbine and Cisplatin for the Treatment of Recurrent and/or Metastatic Carcinoma of the Uterine Cervix

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 31-37

Karger

Access to resources Recommend Favorite

A Pilot Phase II Study of Capecitabine in Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 64, Iss. 3, 2003-04 ,pp. : 232-236

Karger

Access to resources Recommend Favorite

Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 145-150

Karger

Access to resources Recommend Favorite

Phase II Study of Weekly Irinotecan plus Cisplatin in Patients with Previously Untreated Extensive-Stage Extrapulmonary Small Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 34, Iss. 7, 2011-06 ,pp. : 378-381

Karger

Access to resources Recommend Favorite

Phase II Study of Docetaxel and Capecitabine in Patients with Metastatic or Recurrent Gastric Cancer

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 190-195

Karger

Access to resources Recommend Favorite